Initial Single Centre Experience with The XVIVO Hypothermic Perfusion System: Outcomes from the First 32 Cases

Purpose: The initial Australian-New Zealand Non-ischaemic hypothermic perfusion (NIHP) trial demonstrated the feasibility of using the XVIVO non-ischaemic hypothermic perfusion (NIHP) system in prolonged organ preservation, improving the number of available donor hearts for all transplant centres within the region. The device has now been in use for 2 years at St Vincent ’s Hospital, Sydney, Australia and this paper will highlight the post-transplant outcomes from the first 32 patients who received donor hearts preserved by this device.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research